Washington State Citizen Commission for Performance Measurement of Tax Preferences
(WA Commission for Measurement of Tax Preferences)

A mostly new team at the DOH Medical Cannabis Program solicited feedback on potential revisions to rules on compliant products, testing, labeling, and logos.

Legislation expanding arrest projections for medical cannabis patients reflected the diligence of an advocate who had been pushing for various reforms on medical policies for several years.

The Governor was scheduled to take action on two cannabis bills, including the social equity program expansion, while other bodies convened to consider regular session outcomes.

Unanimously supportive testimony on a bill to remove the cannabis excise tax for medical patients registered with the state called attention to problems around taxing medicine.

A busy week inclusive of hearings on a local ban, medical cannabis taxation, social equity, and product testing would culminate in a legislative work session setting the stage for 2022.

A single patient offered testimony recommending sales tax breaks be reserved for registered patient purchases of DOH compliant products to incentivize “medical grade” production.

Summer is “officially” over as judged by policymaking on traceability, 2022 legislation, synthesized cannabinoids, and medical cannabis taxation in the week ahead.

Commissioners learned about tax exemptions for medical patients and cooperatives, and the potentially dramatic impact of a statutory change redefining eligible cannabis purchases.

The agencies on the Cannabis Science Task Force were scheduled to describe their potential request legislation packages intended to create a new body for oversight of testing labs.

Deliberative work characteristic of the interim between legislative sessions began in earnest this week with social equity, medical marijuana, and behavioral health events on the calendar.